Friday, 4 September 2026European Markets
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· December 5, 2025

Bank of America Shares Climb 23.1% YTD: Is It Too Late to Buy?

View original at finance.yahoo.com
Bank of America Shares Climb 23.1% YTD: Is It Too Late to Buy? Shares of Bank of America BAC, the second-largest U.S. bank, are poised for another year of double-digit gains, building on its strong 30.5% rally in 2024…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Bank of America aims to achieve earnings growth of almost 12% in the medium term

    80% confidence
  • Zacks Consensus Estimate for 2026 earnings per share is $4.35

    80% confidence
  • JPMorgan anticipates 2025 NII to be $95.8 billion, up more than 3% year over year

    80% confidence
  • Bank of America carries a Zacks Rank #2 (Buy)

    80% confidence
  • Bank of America targets mid-single-digit CAGR in IB fees and a 50 to 100-bp market share gain over the medium term

    80% confidence
  • Bank of America targets a 55-59% efficiency ratio

    80% confidence
  • Bank of America projects a 5-7% year-over-year increase in NII for 2026, after similar growth this year

    80% confidence
  • Zacks Consensus Estimate for 2025 earnings per share is $3.80

    80% confidence
  • Citigroup expects NII (excluding Markets) to grow 5.5% for 2025

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Funding Surge: Capital Floods Fintech, Foundation Models, and Autonomous Systems
A concentrated burst of AI-linked funding on 2026-08-28 pushed well over $1.5B into companies spanning fraud/identity fintech (Socure, which also acquired Fravity), foundation models (Stability AI), AI agents and enterprise tooling (Instinct, Generalist AI, Emerald AI, Owner), and AI-adjacent autonomous/aerospace ventures (Gatik, Regent Craft). The breadth and simultaneity of these rounds signal that investor appetite for AI is not concentrated in a single vertical but is broadening into applied and infrastructure-adjacent domains, with consolidation (Socure-Fravity) beginning alongside fresh capital formation.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,269 source documents archived
Query this data → isubstrate.com